000 01321 a2200409 4500
005 20250514023633.0
264 0 _c20020321
008 200203s 0 0 eng d
022 _a0004-3591
024 7 _a10.1002/art.10082
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKaiser, M -J
245 0 0 _aEffect of etanercept on tenosynovitis and nodules in rheumatoid arthritis.
_h[electronic resource]
260 _bArthritis and rheumatism
_cFeb 2002
300 _a559-60 p.
_bdigital
500 _aPublication Type: Clinical Trial; Letter
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntirheumatic Agents
_xadministration & dosage
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aChild
650 0 4 _aEtanercept
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulin G
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aReceptors, Tumor Necrosis Factor
_xadministration & dosage
650 0 4 _aTenosynovitis
_xdrug therapy
700 1 _aBozonnat, M -C
700 1 _aJorgensen, C
700 1 _aDaurès, J -P
700 1 _aSany, J
773 0 _tArthritis and rheumatism
_gvol. 46
_gno. 2
_gp. 559-60
856 4 0 _uhttps://doi.org/10.1002/art.10082
_zAvailable from publisher's website
999 _c11749336
_d11749336